Dr Warwick Tong | Chair
Warwick Tong has more than 25 years’ experience in the pharmaceutical and biotechnology sector. Following his first career as a primary care physician in NZ he has worked in medical, drug development and commercial roles in NZ, Singapore, London, Boston and Melbourne. Until April 2018 he was the CEO of the Cancer Therapeutics CRC (CTx) leading it through a period of commercial success and positioning it, post CRC Program funding, for a future as a sustainable oncology biotech company. He currently serves as Board Chair of CTxONE (commercialisation company of CTx), Board Chair of ASX-listed Innate Immunotherapeutics and is a member of the Industry Advisory Board, School of Biomedical Sciences University of Melbourne, the Governance Board of ARC Centre of Excellence for Convergent Bio-Nano Science and Technology, and the Scientific Advisory Board of the Maurice Wilkins Centre in Auckland NZ. Warwick holds a Medical Degree from the University of Auckland, a Master of Public Policy from Victoria University, Wellington NZ and is a Graduate of the Australian Institute of Company Directors.
Mrs Jane Bell
Jane Bell is a banking and finance lawyer and non-executive director with more than 30 years’ experience in leading law firms, financial services, corporate treasury operations and governance gained living in Melbourne, London, Toronto, San Francisco and Brisbane. Jane currently serves as a Director of UCA Funds Management Limited, Monash Health, Jessie McPherson Private Hospital and as Chair of the Advisory Committee of the Melbourne Genomics Health Alliance. Jane is a former Board member of Melbourne Health, WorkSafe Victoria, Monash Institute of Medical Research-Prince Henry’s Institute of Medical Research, Queensland Institute of Medical Research, Victorian Women’s Housing Association, Australian Red Cross (Qld) and Deputy Chair of Westernport Water Corporation. Jane holds a Bachelor of Laws from the University of Melbourne, Bachelor of Economics from Monash University and a Master of Laws from Kings College, London and is a Fellow of the Australian Institute of Company Directors.
Dr Keith McLean
Keith McLean has a BSc and PhD from the University of Aberdeen, Scotland. Following work in industry he undertook postdoctoral research in Scotland and New Zealand before joining the Commonwealth Scientific and Industrial Research Organisation (CSIRO) working on surface modification and characterisation for ophthalmic and other polymeric biomaterials applications. He was Research Director for Biomedical Materials and Devices from 2006-2014 leading a multi-disciplinary team of materials scientists and biologists developing biomaterials and implantable devices. He won the 2004 Royal Societies of Australia Eureka Award for Interdisciplinary Research and the 2009 CSIRO Medal for Research Achievement. In 2014 Keith became Director of CSIRO Manufacturing leading >400 scientists working in chemical, biomedical and advanced manufacturing. McLean also sits on the Board of CRC Polymers; HySSIL Pty Ltd; and veski. Dr McLean sits on a number of Boards and is an Adjunct Professor at Monash University and a Fellow Biomaterials Science and Engineering (FBSE).
Professor Jeffrey Zajac
Jeffrey Zajac is Professor of Medicine and Head of the Department of Medicine, Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. He is the Chairman of the Division of Medicine; Medical Director of the Medical and Emergency CSU and Director of the Department of Endocrinology at Austin Health. He is a Clinical Endocrinologist with research interests in clinical and molecular endocrinology. Professor Zajac trained in Medicine at the University of Melbourne and undertook a PhD in the Department of Medicine, Austin & Repatriation Medical Centre. Following postdoctoral work in the Endocrine Genetics Unit at Massachusetts General Hospital, Boston, he returned to the University of Melbourne initially at Royal Melbourne Hospital and now Austin Health. His clinical research group has had a long-term major research program investigating the function of androgens and androgen withdrawal in patients with prostate cancer. These investigations include effects on bone, muscle, cardiovascular risk and metabolic state. He also heads a molecular endocrinology group who use genetically modified mice to investigate two major areas of endocrinology, functions of the androgen receptor and regulation of calcium metabolism. His clinical interests include general endocrinology, the use, misuse and abuse of testosterone and transgender medicine.
Professor Peter Rogers
Peter Rogers is the Professor of Women’s Health Research, University of Melbourne Department of Obstetrics and Gynaecology (2010 to present), and Director of Research, Royal Women’s Hospital, Melbourne, Australia (2012 to present). He is also a founding and current Board Member of the Jean Hailes Foundation (1992 to present). His research interests cover most aspects of female reproductive biology including endometriosis, heavy menstrual bleeding, uterine fibroids, pelvic pain, implantation and uterine receptivity. Following a PhD at Flinders University in South Australia, he worked as a scientist at Monash IVF from 1983-1993 in positions that included Scientific Director of Monash IVF and consultant to IVF Australia establishing clinics in the USA. From 1993-2010 he worked full time research as a NHMRC Fellow, Monash University Dept. O&G, including 10 years as founding director of the Centre for Women’s Health Research. He has held numerous leadership positions including Chair of the Victorian Cancer Biobank Consortium (2008-10).
Dr Megan Robertson
Dr Megan Robertson is an alumna of the University of Melbourne where she completed a Bachelor of Medicine, Bachelor of Surgery (MBBS). She is the current Director of Research at St Vincent’s Hospital, Melbourne, and works as a Senior Intensivist at Epworth HealthCare (Richmond and Freemasons). She is on the boards of BioMedical Research Victoria, the Caroline Chisolm Centre for Health Ethics and FearLess (PTSD-ANZ), the Biodevices Advisory Board at the ARC Training Centre in Biodevices at Swinburne University, and the Tuckwell Scholarship Selection Panel at ANU. She also works with national bodies including the Australian Commission on Safety and Quality in Healthcare, AusBioTech, and the National Health and Medical Research Council. Previously, she held positions as the Director of Professional Affairs, CICM, as the Executive Director of Research at Epworth HealthCare, and as the Co-Director of the Intensive Care Unit at Epworth Freemasons.